Clinical Neuroscience Solutions

Running trials

• Recruiting

  Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  NCT07837973· Phase 2· Source

• Recruiting

  A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

  NCT07609914· Phase 4· Source

• Recruiting

  Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  NCT07575399· Phase 3· Source

• Active, not recruiting

  A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

  NCT03432286· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity2 recruiting
• Migraine1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine

  NCT06578585· Phase 1· Source

• Completed

  Single and Multiple Ascending Dose Study of AMG 513 in Participants With Obesity

  NCT06585462· Phase 1· Source

• Completed

  A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

  NCT06254612· Phase 2· Source

• Completed

  A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

  NCT05929066· Phase 3· Source

• Completed

  A Study of JNJ-55308942 in the Treatment of Bipolar Depression

  NCT05328297· Phase 2· Source